Today, the Pennsylvania Department of Drug and Alcohol Programs (DDAP) issued Licensing Alert 01-2023 to detail continued expansion of the availability of take-home methadone through the ongoing suspension of 28 Pa. Code § 715.16(e).
On Feb. 9, 2023, the US Department of Health and Human Services announced the final renewal of the federal public health emergency (PHE) declaration. The PHE will not be renewed when it expires on May 11, 2023. Both the federal and Pennsylvania Department of Drug and Alcohol Programs’ (DDAP) expansions of the availability of take-home methadone will remain in place until May 11, 2024. DDAP will keep the field aware of developments at the federal level that could extend flexibilities beyond May 2024. Read the full alert and background information on the regulatory suspension.